Skip to Main Content

Paper Details

ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.
Sci Adv
2
2023
Author NameAffiliation
Anuradha GopalanMemorial Sloan Kettering Cancer Center
Nora M NavoneMD Anderson Cancer Center
Yu ChenMemorial Sloan Kettering Cancer Center
Yu Chen
Yu ChenMemorial Sloan Kettering Cancer Center
Yu Chen
Yu ChenMemorial Sloan Kettering Cancer Center
  • 1 - 7

Datasets

Release 1.2